1
|
Diaz AA. Seeing and Not Seeing Is Believing: Predicting COPD With Lung Imaging. Chest 2023; 164:1069-1070. [PMID: 37945184 DOI: 10.1016/j.chest.2023.07.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2023] [Accepted: 07/11/2023] [Indexed: 11/12/2023] Open
Affiliation(s)
- Alejandro A Diaz
- Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA.
| |
Collapse
|
2
|
Makimoto K, Hogg JC, Bourbeau J, Tan WC, Kirby M. CT Imaging With Machine Learning for Predicting Progression to COPD in Individuals at Risk. Chest 2023; 164:1139-1149. [PMID: 37421974 DOI: 10.1016/j.chest.2023.06.008] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2023] [Revised: 05/26/2023] [Accepted: 06/05/2023] [Indexed: 07/10/2023] Open
Abstract
BACKGROUND Identifying individuals at risk of progressing to COPD may allow for initiation of treatment to potentially slow the progression of the disease or the selection of subgroups for discovery of novel interventions. RESEARCH QUESTION Does the addition of CT imaging features, texture-based radiomic features, and established quantitative CT scan to conventional risk factors improve the performance for predicting progression to COPD in individuals who smoke with machine learning? STUDY DESIGN AND METHODS Participants at risk (individuals who currently or formerly smoked, without COPD) from the Canadian Cohort Obstructive Lung Disease (CanCOLD) population-based study underwent CT imaging at baseline and spirometry at baseline and follow-up. Various combinations of CT scan features, texture-based CT scan radiomics (n = 95), and established quantitative CT scan (n = 8), as well as demographic (n = 5) and spirometry (n = 3) measurements, with machine learning algorithms were evaluated to predict progression to COPD. Performance metrics included the area under the receiver operating characteristic curve (AUC) to evaluate the models. DeLong test was used to compare the performance of the models. RESULTS Among the 294 at-risk participants who were evaluated (mean age, 65.6 ± 9.2 years; 42% female; mean pack-years, 17.9 ± 18.7), 52 participants (23.7%) in the training data set and 17 participants (23.0%) in the testing data set progressed to spirometric COPD at follow-up (2.5 ± 0.9 years from baseline). Compared with machine learning models with demographics alone (AUC, 0.649), the addition of CT imaging features to demographics (AUC, 0.730; P < .05) or CT imaging features and spirometry to demographics (AUC, 0.877; P < .05) significantly improved the performance for predicting progression to COPD. INTERPRETATION Heterogeneous structural changes occur in the lungs of individuals at risk that can be quantified using CT imaging features, and evaluation of these features together with conventional risk factors improves performance for predicting progression to COPD.
Collapse
Affiliation(s)
| | - James C Hogg
- Center for Heart, Lung Innovation, University of British Columbia, Vancouver, BC, Canada
| | - Jean Bourbeau
- Montreal Chest Institute of the Royal Victoria Hospital, McGill University Health Centre, Montreal, QC, Canada; Respiratory Epidemiology and Clinical Research Unit, Research Institute of McGill University Health Centre, Montreal, QC, Canada
| | - Wan C Tan
- Center for Heart, Lung Innovation, University of British Columbia, Vancouver, BC, Canada
| | - Miranda Kirby
- Toronto Metropolitan University, Toronto, ON, Canada.
| |
Collapse
|
3
|
Xu S, Deo RC, Soar J, Barua PD, Faust O, Homaira N, Jaffe A, Kabir AL, Acharya UR. Automated detection of airflow obstructive diseases: A systematic review of the last decade (2013-2022). COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE 2023; 241:107746. [PMID: 37660550 DOI: 10.1016/j.cmpb.2023.107746] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/02/2023] [Revised: 07/07/2023] [Accepted: 08/02/2023] [Indexed: 09/05/2023]
Abstract
BACKGROUND AND OBJECTIVE Obstructive airway diseases, including asthma and Chronic Obstructive Pulmonary Disease (COPD), are two of the most common chronic respiratory health problems. Both of these conditions require health professional expertise in making a diagnosis. Hence, this process is time intensive for healthcare providers and the diagnostic quality is subject to intra- and inter- operator variability. In this study we investigate the role of automated detection of obstructive airway diseases to reduce cost and improve diagnostic quality. METHODS We investigated the existing body of evidence and applied Preferred Reporting Items for Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to search records in IEEE, Google scholar, and PubMed databases. We identified 65 papers that were published from 2013 to 2022 and these papers cover 67 different studies. The review process was structured according to the medical data that was used for disease detection. We identified six main categories, namely air flow, genetic, imaging, signals, and miscellaneous. For each of these categories, we report both disease detection methods and their performance. RESULTS We found that medical imaging was used in 14 of the reviewed studies as data for automated obstructive airway disease detection. Genetics and physiological signals were used in 13 studies. Medical records and air flow were used in 9 and 7 studies, respectively. Most papers were published in 2020 and we found three times more work on Machine Learning (ML) when compared to Deep Learning (DL). Statistical analysis shows that DL techniques achieve higher Accuracy (ACC) when compared to ML. Convolutional Neural Network (CNN) is the most common DL classifier and Support Vector Machine (SVM) is the most widely used ML classifier. During our review, we discovered only two publicly available asthma and COPD datasets. Most studies used private clinical datasets, so data size and data composition are inconsistent. CONCLUSIONS Our review results indicate that Artificial Intelligence (AI) can improve both decision quality and efficiency of health professionals during COPD and asthma diagnosis. However, we found several limitations in this review, such as a lack of dataset consistency, a limited dataset and remote monitoring was not sufficiently explored. We appeal to society to accept and trust computer aided airflow obstructive diseases diagnosis and we encourage health professionals to work closely with AI scientists to promote automated detection in clinical practice and hospital settings.
Collapse
Affiliation(s)
- Shuting Xu
- School of Mathematics Physics and Computing, University of Southern Queensland, Springfield Central, QLD 4300, Australia; Cogninet Australia, Sydney, NSW 2010, Australia
| | - Ravinesh C Deo
- School of Mathematics Physics and Computing, University of Southern Queensland, Springfield Central, QLD 4300, Australia
| | - Jeffrey Soar
- School of Business, University of Southern Queensland, Australia
| | - Prabal Datta Barua
- Cogninet Australia, Sydney, NSW 2010, Australia; School of Business, University of Southern Queensland, Australia; Faculty of Engineering and Information Technology, University of Technology Sydney, Sydney, NSW 2007, Australia; Australian International Institute of Higher Education, Sydney, NSW 2000, Australia; School of Science Technology, University of New England, Australia; School of Biosciences, Taylor's University, Malaysia; School of Computing, SRM Institute of Science and Technology, India; School of Science and Technology, Kumamoto University, Japan; Sydney School of Education and Social Work, University of Sydney, Australia.
| | - Oliver Faust
- School of Computing and Information Science, Anglia Ruskin University Cambridge Campus, UK
| | - Nusrat Homaira
- School of Clinical Medicine, University of New South Wales, Australia; Sydney Children's Hospital, Sydney, Australia; James P. Grant School of Public Health, Dhaka, Bangladesh
| | - Adam Jaffe
- School of Clinical Medicine, University of New South Wales, Australia; Sydney Children's Hospital, Sydney, Australia
| | | | - U Rajendra Acharya
- School of Mathematics Physics and Computing, University of Southern Queensland, Springfield Central, QLD 4300, Australia; School of Science and Technology, Kumamoto University, Japan
| |
Collapse
|
4
|
Suzuki M, Matsumoto I, Ishida M, Horie Y, Ban H, Takeuchi W, Nakagawa S, Nakagawa T, Kitamura T, Muro S. Investigation of time profile of FEV 1 across the onset of potential COPD: a retrospective cohort study using medical checkup data in Japan. Sci Rep 2023; 13:5454. [PMID: 37012340 PMCID: PMC10070435 DOI: 10.1038/s41598-023-32205-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2022] [Accepted: 03/24/2023] [Indexed: 04/05/2023] Open
Abstract
This study compared the time profile of FEV1 after COPD diagnosis among rapid decliners, slow decliners, and sustainers in the year of COPD diagnosis. COPD subjects were identified from the annual medical checkup records of Hitachi, Ltd., employees in Japan (April 1998-March 2019). Subjects were categorized into 3 groups (rapid decliner [decrease of FEV1 ≥ 63 mL/year], slow decliner [< 63 and ≥ 31 mL/year], and sustainer [< 31 mL/year]) for 5 years. The time profile of FEV1 was compared using mixed-effects model for 5 years after diagnosis; risk factors of rapid decliner were detected using logistic model/gradient boosting decision tree. Of 1294 eligible subjects, 18.6%, 25.7%, and 55.7% were classified as rapid decliners, slow decliners, and sustainers, respectively. The annual rates of FEV1 decline were similar 3 years before and until COPD diagnosis. The mean FEV1 in rapid decliners was 2.82 ± 0.04 L in year 0 and 2.41 ± 0.05 L in year 5, and in sustainers, it was 2.67 ± 0.02 L and 2.72 ± 0.02 L (year 0, p = 0.0004). In conclusion, FEV1 declined yearly before diagnosis and the time profiles of FEV1 were different in the 3 groups after COPD diagnosis. Therefore, appropriate treatment of the 3 groups with regular lung function tests is necessary to follow FEV1 decline after COPD onset.
Collapse
Affiliation(s)
- Masaru Suzuki
- Department of Respiratory Medicine, Faculty of Medicine, Hokkaido University, Sapporo, Japan
| | - Isao Matsumoto
- Department of Respiratory, Inflammation, and Autoimmune, Medical, AstraZeneca K.K., Osaka, Japan.
| | - Masato Ishida
- Department of Respiratory, Inflammation, and Autoimmune, Medical, AstraZeneca K.K., Osaka, Japan
| | - Yoshiharu Horie
- Department of Data Science, Medical, AstraZeneca K.K., Osaka, Japan
- Division of Environmental Medicine and Population Sciences, Department of Social and Environmental Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan
| | - Hideyuki Ban
- Healthcare IT Research Department, Center for Digital Services-Healthcare, Hitachi, Ltd. Research and Development Group, Tokyo, Japan
| | - Wataru Takeuchi
- Healthcare IT Research Department, Center for Digital Services-Healthcare, Hitachi, Ltd. Research and Development Group, Tokyo, Japan
| | - Shunki Nakagawa
- Healthcare IT Research Department, Center for Digital Services-Healthcare, Hitachi, Ltd. Research and Development Group, Tokyo, Japan
| | - Tohru Nakagawa
- Hitachi Health Care Center, Hitachi, Ltd., Ibaraki, Japan
| | - Tetsuhisa Kitamura
- Division of Environmental Medicine and Population Sciences, Department of Social and Environmental Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan
| | - Shigeo Muro
- Department of Respiratory Medicine, Nara Medical University, Nara, Japan
| |
Collapse
|
5
|
Prediction of mortality risk of health checkup participants using machine learning-based models: the J-SHC study. Sci Rep 2022; 12:14154. [PMID: 35986034 PMCID: PMC9391467 DOI: 10.1038/s41598-022-18276-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2022] [Accepted: 08/09/2022] [Indexed: 11/10/2022] Open
Abstract
Early detection and treatment of diseases through health checkups are effective in improving life expectancy. In this study, we compared the predictive ability for 5-year mortality between two machine learning-based models (gradient boosting decision tree [XGBoost] and neural network) and a conventional logistic regression model in 116,749 health checkup participants. We built prediction models using a training dataset consisting of 85,361 participants in 2008 and evaluated the models using a test dataset consisting of 31,388 participants from 2009 to 2014. The predictive ability was evaluated by the values of the area under the receiver operating characteristic curve (AUC) in the test dataset. The AUC values were 0.811 for XGBoost, 0.774 for neural network, and 0.772 for logistic regression models, indicating that the predictive ability of XGBoost was the highest. The importance rating of each explanatory variable was evaluated using the SHapley Additive exPlanations (SHAP) values, which were similar among these models. This study showed that the machine learning-based model has a higher predictive ability than the conventional logistic regression model and may be useful for risk assessment and health guidance for health checkup participants.
Collapse
|
6
|
Machine Learning Approaches for Predicting Acute Respiratory Failure, Ventilator Dependence, and Mortality in Chronic Obstructive Pulmonary Disease. Diagnostics (Basel) 2021; 11:diagnostics11122396. [PMID: 34943632 PMCID: PMC8700350 DOI: 10.3390/diagnostics11122396] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2021] [Revised: 11/26/2021] [Accepted: 12/18/2021] [Indexed: 01/21/2023] Open
Abstract
Chronic obstructive pulmonary disease (COPD) is one of the leading causes of mortality and contributes to high morbidity worldwide. Patients with COPD have a higher risk for acute respiratory failure, ventilator dependence, and mortality after hospitalization compared with the general population. Accurate and early risk detection will provide more information for early management and better decision making. This study aimed to build prediction models using patients’ characteristics, laboratory data, and comorbidities for early detection of acute respiratory failure, ventilator dependence, and mortality in patients with COPD after hospitalization. We retrospectively collected the electronic medical records of 5061 patients with COPD in three hospitals of the Chi Mei Medical Group, Taiwan. After data cleaning, we built three prediction models for acute respiratory failure, ventilator dependence, and mortality using seven machine learning algorithms. Based on the AUC value, the best model for mortality was built by the XGBoost algorithm (AUC = 0.817), the best model for acute respiratory failure was built by random forest algorithm (AUC = 0.804), while the best model for ventilator dependence was built by LightGBM algorithm (AUC = 0.809). A web service application was implemented with the best models and integrated into the existing hospital information system for physician’s trials and evaluations. Our machine learning models exhibit excellent predictive quality and can therefore provide physicians with a useful decision-making reference for the adverse prognosis of COPD patients.
Collapse
|